Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (1)

Sponsor

Nicola Goekbuget (1)

University of Nebraska (1)

Collaborator

Intervention

inotuzumab ozogamicin (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

precursor cell lymphoblastic leukemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Precursor Cell Lymphoblastic Leukemia Trial in Germany (Inotuzumab ozogamicin)

Recruiting

Precursor Cell Lymphoblastic Leukemia

Inotuzumab ozogamicin

Augsburg, Germany
+13 more

Oct 31, 2022

Healthy Bones, Healthy Life

Recruiting

Acute Lymphoblastic Leukemia, Pediatric
+12 more

Omaha, Nebraska

University of Nebraska Medical Center

Dec 10, 2021